How Much Does Rybelsus Cost? (2026)
Rybelsus (oral semaglutide) is the original pill-form GLP-1 medication, FDA-approved for type 2 diabetes. At $936/month list price, it's not cheap — but it remains the only oral semaglutide option for diabetes management. Here's what you'll actually pay and how it compares to alternatives.
Quick Answer
What Is Rybelsus?
Rybelsus is the brand name for oral semaglutide, manufactured by Novo Nordisk. It was FDA-approved in September 2019 as the first GLP-1 receptor agonist available in pill form, specifically for improving blood sugar control in adults with type 2 diabetes.
Unlike injectable GLP-1 medications like Ozempic and Wegovy, Rybelsus is taken as a daily tablet. It must be swallowed on an empty stomach with no more than 4 ounces (120 mL) of plain water, at least 30 minutes before the first food, drink, or other oral medication of the day.
Important distinction: Rybelsus is FDA-approved only for type 2 diabetes, not for weight loss. While patients do experience weight loss as a side effect, the doses available (3mg, 7mg, 14mg) are lower than those used in Oral Wegovy (up to 50mg), which is specifically approved for weight management.
Rybelsus List Price by Dose
The wholesale acquisition cost (WAC) for Rybelsus is the same across all three dose levels:
- 3 mg (starting dose, first 30 days): $936/month
- 7 mg (maintenance dose): $936/month
- 14 mg (maximum dose): $936/month
At retail pharmacies without insurance, you will pay approximately $936/month. This makes Rybelsus slightly cheaper than Ozempic ($998/month) at list price, though the difference is marginal. Discount pharmacy programs like GoodRx may reduce the cash price to approximately $750-$900/month depending on your location.
For comparison, the same medication costs roughly $70/month in Germany and $130/month in Canada. The U.S. price premium reflects the same pharmaceutical pricing dynamics that affect all GLP-1 medications.
Rybelsus Cost With Insurance
Because Rybelsus is FDA-approved for type 2 diabetes (not weight loss), it generally has better insurance coverage than weight-management-specific medications like Wegovy and Zepbound:
Preferred Commercial Plans
$25–$50/moMany diabetes formularies include Rybelsus as a preferred or covered option. With the Novo Nordisk savings card, copays can drop to as low as $10/month.
Non-Preferred Plans
$100–$200/moSome plans place Rybelsus on a non-preferred tier or require step therapy (trying metformin first). Prior authorization may be required.
Medicare Part D
$35–$100/moMedicare covers Rybelsus for type 2 diabetes under Part D. Copay varies by plan and coverage phase. The IRA $2,000 annual out-of-pocket cap helps limit total costs.
Medicaid
$0–$10/moMost state Medicaid programs cover Rybelsus for diabetes. Copays are typically minimal or zero. Coverage may require prior authorization.
Key advantage: Rybelsus generally has better insurance coverage than Wegovy or Zepbound because it is approved for diabetes — a recognized medical condition — rather than weight management, which many insurers still classify as a lifestyle concern.
Savings Programs and Discounts
Novo Nordisk Savings Card
As low as $10/moCommercially insured patients may pay as little as $10/month for Rybelsus. The savings card covers the difference between your copay and $10. Valid for up to 24 months. Cannot combine with Medicare, Medicaid, or government insurance.
NovoCare Patient Assistance
Free medicationProvides free Rybelsus for uninsured patients earning under 400% of the Federal Poverty Level ($62,400/year individual in 2026). Application requires income documentation.
GoodRx / RxSaver Coupons
$750–$900/moPharmacy discount programs can reduce the cash price by $35-$185 depending on your pharmacy. Savings are modest for brand-name biologics but worth checking.
Medicare Extra Help (LIS)
$0–$10/moLow-Income Subsidy program for Medicare beneficiaries. If you qualify, your Part D costs for Rybelsus and other medications are significantly reduced.
Full Price Comparison
Rybelsus compared to every other GLP-1 option in 2026.
| Medication | Monthly Cost | Form | Approved For | Notes |
|---|---|---|---|---|
Rybelsus Oral semaglutide (3-14mg) | $936/mo | Daily tablet | Type 2 diabetes | Current page |
Rybelsus + Savings Card Oral semaglutide | $10–$25/mo | Daily tablet | Type 2 diabetes | Commercial insurance required |
Ozempic Injectable semaglutide | $998/mo | Weekly injection | Type 2 diabetes | Same drug, injectable form |
Oral Wegovy Oral semaglutide (25-50mg) | $149/mo | Daily tablet | Weight management | Higher dose oral semaglutide |
Wegovy Injectable semaglutide | $1,349/mo | Weekly injection | Weight management | Highest semaglutide dose |
Mounjaro Injectable tirzepatide | $1,023/mo | Weekly injection | Type 2 diabetes | Dual GLP-1/GIP |
Zepbound Injectable tirzepatide | $1,060/mo | Weekly injection | Weight management | $349 via LillyDirect |
NovoCare PAP Rybelsus | $0/mo | Daily tablet | Type 2 diabetes | Income under $62,400/yr |
List prices shown unless otherwise noted. Prices are approximate. Last updated March 2026.
Rybelsus vs Oral Wegovy
Both are oral semaglutide tablets made by Novo Nordisk, but they serve different purposes and come at very different price points. Understanding the distinction is critical.
Rybelsus
- --Doses: 3mg, 7mg, 14mg daily
- --Approved for: Type 2 diabetes
- --List price: $936/month
- --Weight loss: Modest (3-5% body weight)
- --Insurance: Well covered for diabetes
Oral Wegovy
- --Doses: 25mg, 50mg daily
- --Approved for: Weight management
- --Self-pay: ~$149/month (starting dose)
- --Weight loss: Significant (15-17% body weight)
- --Insurance: Variable for weight loss
Key takeaway: If your primary goal is diabetes management and you prefer pills over injections, Rybelsus with a savings card ($10-$25/month) is likely your best option. If your primary goal is weight loss, Oral Wegovy at higher doses offers significantly more efficacy. They are not interchangeable — Oral Wegovy uses doses 2-4x higher than Rybelsus.
Rybelsus vs Other GLP-1 Medications
Understanding where Rybelsus fits in the GLP-1 landscape helps you make an informed decision with your doctor:
- Ozempic ($998/month): Same semaglutide molecule but injected weekly. Higher bioavailability means lower doses achieve similar effects. Most endocrinologists consider Ozempic more effective than Rybelsus for blood sugar control at equivalent therapeutic levels. See Ozempic pricing.
- Mounjaro ($1,023/month): Tirzepatide injection for diabetes. Dual GLP-1/GIP mechanism may provide superior blood sugar control and weight loss compared to semaglutide. Requires weekly injections. See Mounjaro pricing.
- Wegovy ($1,349/month):Injectable semaglutide at higher doses for weight loss. If you have both diabetes and obesity, your doctor might prescribe Ozempic for diabetes rather than Rybelsus, given the injectable's greater efficacy. See Wegovy pricing.
- Zepbound ($1,060/month, $349 LillyDirect): Tirzepatide for weight loss. If weight management is your primary concern, LillyDirect pricing makes Zepbound compelling. See Zepbound pricing.
When Rybelsus makes sense: Rybelsus is the best choice when you have type 2 diabetes, want to avoid injections, have good insurance coverage for diabetes medications, and weight loss is a secondary benefit rather than your primary goal.
Frequently Asked Questions
How much does Rybelsus cost per month?
Is Rybelsus the same as Ozempic in pill form?
Does Rybelsus help with weight loss?
Is there a generic version of Rybelsus?
Can I take Rybelsus with other diabetes medications?
What is the difference between Rybelsus and Oral Wegovy?
Compare All GLP-1 Medications by Cost
See how Rybelsus compares to Ozempic, Wegovy, Zepbound, and Mounjaro across every pricing option and insurance scenario.